1. Home
  2. STGW vs ARDX Comparison

STGW vs ARDX Comparison

Compare STGW & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stagwell Inc.

STGW

Stagwell Inc.

HOLD

Current Price

$6.07

Market Cap

1.6B

Sector

N/A

ML Signal

HOLD

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$6.24

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STGW
ARDX
Founded
1980
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2006
2014

Fundamental Metrics

Financial Performance
Metric
STGW
ARDX
Price
$6.07
$6.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
7
Target Price
$8.39
$15.14
AVG Volume (30 Days)
1.3M
4.1M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,909,000,000.00
$2,607,000.00
Revenue This Year
$13.27
$37.75
Revenue Next Year
$4.07
$34.24
P/E Ratio
N/A
N/A
Revenue Growth
2.39
N/A
52 Week Low
$4.03
$3.54
52 Week High
$7.52
$8.40

Technical Indicators

Market Signals
Indicator
STGW
ARDX
Relative Strength Index (RSI) 41.63 45.83
Support Level $5.86 $5.54
Resistance Level $6.50 $6.44
Average True Range (ATR) 0.27 0.36
MACD -0.08 -0.05
Stochastic Oscillator 25.17 27.02

Price Performance

Historical Comparison
STGW
ARDX

About STGW Stagwell Inc.

Stagwell Inc is a challenger network using AI to deliver marketing and advertising solutions to its clients. It operates in five reportable segments: Marketing Services, Digital Transformation, Media and Commerce, Communications, and The Marketing Cloud. Maximum revenue is generated from the Marketing Services segment, which offers social media solutions, designs breakthrough brand campaigns, and creates immersive experiential marketing programs and social engagement strategies, helping clients connect with audiences across digital platforms. The various brands operating under this segment include 72 and Sunny, Anomaly, NRG, Harris Insights, TEAM, and Movers & Shaker. Geographically, the company generates maximum revenue from the United States, followed by the UK and other countries.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: